THE IMPACT OF PROTON PUMP INHIBITORS ON KIDNEY FAILURE: LITERATURE REVIEW
Authors:
- Natalia BednarczykNBNatalia Bednarczyk
- Rafał BednarczykRBRafał Bednarczyk
- Radosław Krzysztof BinkowskiRBRadosław Krzysztof Binkowski
- Agnieszka KurekAKAgnieszka Kurek
- Natalia KrajewskaNKNatalia Krajewska
- Aleksandra LejmanALAleksandra Lejman
- Aleksandra MazurkiewiczAMAleksandra Mazurkiewicz
- Hubert SidorHSHubert Sidor
- Monika WołosikMWMonika Wołosik
- Szymon ZysiakSZSzymon Zysiak
Open Access
- 6 January 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Abstract
Proton pump inhibitors (PPIs) are among the world's most frequently prescribed medications for treating acid-related gastrointestinal disorders. Increasing evidence from the past decade has raised concerns about their potential adverse effects on kidney function. This review examines multiple dimensions of PPI-associated nephrotoxicity, including acute interstitial nephritis (AIN), acute kidney injury (AKI), chronic kidney disease (CKD), progression and end-stage renal disease (ESRD). Multiple observational studies and meta-analyses have demonstrated connections between PPI use and adverse renal outcomes. The underlying mechanisms remain incompletely understood. The evidence suggests that PPIs may contribute to kidney dysfunction through various pathways, including immune-mediated reactions, alterations in magnesium homeostasis, changes in renal blood flow, and potential effects on gut microbiome-derived uremic toxins. While some recent studies challenge the strength of these correlations, the weight of evidence indicates a need for more judicious PPI prescribing, particularly in patients with existing kidney disease or risk factors for renal dysfunction. This work provides healthcare professionals with an understanding of current evidence, proposed mechanisms, clinical implications, and recommendations for PPI use in the context of kidney health.Keywords
This publication has 37 references indexed in Scilit:
- Proton Pump Inhibitor Use and Worsening Kidney Function: A Retrospective Cohort Study Including 122,606 Acid-Suppressing UsersJournal of General Internal Medicine, 2024
- Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradationChemico-Biological Interactions, 2022
- Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced NephrotoxicityDrug Safety, 2022
- The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4The American Journal of the Medical Sciences, 2021
- Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort StudyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
- Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injuryKidney International, 2017
- PPIs and kidney disease: from AIN to CKDJournal Of Nephrology, 2016
- Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?Kidney International, 2016
- Proton Pump Inhibitor Use and the Risk of Chronic Kidney DiseaseJAMA Internal Medicine, 2016
- Proton Pump Inhibitors and Acute Interstitial NephritisClinical Gastroenterology and Hepatology, 2006